Transanal Endoscopic Microsurgery Versus Endoscopic Submucosal Dissection For Large Rectal Adenomas
NCT01023984 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2023-09-08
Summary
Objective: Recent non-randomized studies suggest that extended endoscopic submucosal dissection (ESD) is equally effective in removing large rectal adenomas as transanal endoscopic microsurgery (TEM). If equally effective, ESD might be a more cost-effective approach as this strategy does not require expensive equipment, general anesthesia and hospital admission. Furthermore, ESD appears to be associated with fewer complications. In a randomized trial we will compare the cost-effectiveness and cost-utility of TEM and ESD for the resection of large rectal adenomas.
Study design: 15 centers will participate in this multicenter randomized trial comparing TEM versus ESD.
Study population: Patients with a large rectal adenoma (≥2cm), located between 2 and 15 cm from the anal verge. Invasive cancer is excluded by histopathology and endoscopic ultrasonography. Patients must be in a health condition that permits general anesthesia.
Interventions: Patients will be randomized between
a. TEM: under general anesthesia b. ESD under sedation
1. a TEM tube will be inserted in the rectum. With specialized instruments the adenoma will be dissected en bloc by a full thickness excision, after which the patient will be admitted to the hospital.
2. an endoscope will be inserted into the rectum and the submucosa underneath the lesion will be injected with saline to lift the adenoma. With an endoscopic knife (Insulated Tip Knife, Olympus or Water Jet, Erbe) the lesion will be resected through the submucosal plane in an eb-bloc fashion, after which the patient will be observed for at least 24h in-hospital.
Primary Endpoint: incidence of recurrence at 12 months
Secondary Endpoints:
morbidity, subdivided into major (requiring surgery) and minor (requiring endoscopic or medical intervention) anorectal function. disease specific and general quality of life; number of days not spent in hospital from initial treatment until 2 years afterwards; adenoma
Sample size: Assuming a comparable baseline recurrence rate for TEM and ESD of 6% and considering an upper limit of 10% for ESD to be non-inferior (beta-error 0.2 and one-sided alpha-error 0.05), 60 patients are needed per group. These numbers provide sufficient power to reveal relevant differences in expected morbidity and in number of days not spent in hospital.
Economic evaluation: A cost-effectiveness and cost-utility analysis of ESD against TEM for large rectal adenomas from a societal perspective with respectively the costs per recurrence free patient and the cost per quality adjusted life year as primary outcome measures.
Conditions
- RECTAL NEOPLASMS
Interventions
- PROCEDURE
-
TEM - Transanal Endoscopic Microsurgery
TEM tube will be inserted in the rectum. With specialized instruments the adenoma will be dissected en bloc by a full thickness excision, after which the patient will be admitted to the hospital.
- PROCEDURE
-
ESD - Endoscopic Submucosal Dissection
an endoscope will be inserted into the rectum and the submucosa underneath the lesion will be injected with saline to lift the adenoma. With an endoscopic knife (Insulated Tip Knife, Olympus or Water Jet, Erbe) the lesion will be resected through the submucosal plane in an eb-bloc fashion, after which the patient will be observed for at least 24h in-hospital.
Sponsors & Collaborators
-
European Association for Endoscopic Surgery
lead OTHER
Principal Investigators
-
Mario Morino, Prof of Surgery · University of Torino
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Recto-Anal-Repair in the Treatment of Advanced Haemorrhoidal Disease
NCT01301209 ·Status: COMPLETED
-
Feasibility, Safety and Outcome of Transrectal Hybrid-NOTES Anterior Resection
NCT01992406 ·Status: UNKNOWN
-
STARR Trans-anal Resection Versus Vaginal Rectocele Repair Using Elevate: Effects on Defecatory Function
NCT01257659 ·Status: TERMINATED ·Phase: NA
-
Assessment of a Slotted Anoscope That Facilitates Hemorrhoidectomy
NCT01264835 ·Status: TERMINATED ·Phase: NA
-
Comparison of Fissurectomy to Fissurectomy With Anoplasty
NCT04911023 ·Status: COMPLETED
-
Surgical Treatment of High Perianal Fistulas
NCT01997645 ·Status: UNKNOWN ·Phase: NA
-
Transcutaneous Posterior Tibial Nerve Stimulation for Treatment of Chronic Anal Fissure
NCT02395809 ·Status: COMPLETED ·Phase: NA
-
Ligation of Intersphincteric Fistula Tract Versus Rectal Advancement Flap in the Treatment of Complex Anal Fistula
NCT05263661 ·Status: UNKNOWN ·Phase: PHASE3
-
Conservative Treatment of Gastrointestinal Fistulas by Endoscopic Injection of tSVFem
NCT04670276 ·Status: UNKNOWN ·Phase: NA
-
The Modified Clipped-LIFT Procedure for High Transsphincteric or Suprasphincteric Fistula
NCT07102134 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Treatment of Complex Anal Fistulas
NCT02585167 ·Status: TERMINATED ·Phase: NA
-
Drainage Seton With Flap Versus EAS Preserving Seton in Treatment of Transsphincteric Anal Fistula
NCT03983174 ·Status: COMPLETED ·Phase: NA
-
Treatment of Anal Fistulas Advancement Flap
NCT01042821 ·Status: COMPLETED ·Phase: NA
-
Fistulectomy and Primary Sphincter rEconstruction vs. endorectaL Advancement Flap in the Treatment of High Anal Fistulas
NCT04119700 ·Status: UNKNOWN ·Phase: NA
-
Endosonograpic Monitoring of Injury to the Anal Sphincter After Transanal Stapled Anastomosis
NCT05992948 ·Status: UNKNOWN
-
Anal Fistula Plug Versus Endorectal Advancement Flap
NCT01931371 ·Status: UNKNOWN ·Phase: NA
-
Feasibility and Safety of Additional Injection of Autologous Platelet-rich Stroma to Surgical Treatment of Rectovaginal Fistulas
NCT06798935 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Study Between Delorme Operation With or Without Postanal Repair in Treatment of Complete Rectal Prolapse
NCT01656369 ·Status: COMPLETED ·Phase: NA
-
Treatment of Perianal Fistulas by Endorectal Advancement Flap Associated With Adipose Tissue Injection
NCT04750499 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy of Human Acellular Dermal Matrix in the Treatment of Anal Fistula
NCT00951002 ·Status: UNKNOWN
-
Multi-Drug Analgesia vs. Standard Solution for Anal Surgery
NCT03105674 ·Status: WITHDRAWN ·Phase: PHASE4
-
Comparative Study of the House Advancement Flap, Rhomboid Flap, and Y-V Anoplasty
NCT00883571 ·Status: COMPLETED ·Phase: NA
-
Comparing Three Surgical Techniques for the Treatment of Transsphincteric Perianal Fistula: (1) Traditional Fistulotomy (Lay Open), (2) Ligation of the Intersphincteric Tract (LIFT) With Adjunctive Endo Fistula Laser Ablation, and (3) Open LIFT Procedure Followed by LASER
NCT07236047 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pre-Emptive Analgesia in Ano-Rectal Surgery
NCT02402543 ·Status: COMPLETED ·Phase: NA
-
Treatment of Fistula in Ano With Autologous Fatty Tissue Cells Transplantation
NCT04660903 ·Status: SUSPENDED ·Phase: NA